To include your compound in the COVID-19 Resource Center, submit it here.

Isis Pharmaceuticals, Biogen Idec deal

Isis received a $2 million milestone payment from Biogen Idec under a 2012 deal under which the company has an exclusive,

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE